The remission rate of myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients who received standard induction therapy is far from satisfactory. The gene discussed is MPO; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.